mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
-0.14 |
0.01 |
mRNA |
StemRegenin 1 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.01 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.01 |
mRNA |
Parthenolide |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
Salubrinal |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.02 |